retatrutide blindness and Thyroid Cancer: Why the Warning Exists Retatrutide for Weight Loss: TRIUMPH-1

In a clinical context, this combination practice will contribute to making weight loss more sustainable and in line with the general health objectives

The phase 2 signal that put retatrutide on the map The pivotal early evidence is the phase 2 trial published in the New England Journal of Medicine in 2023, which randomized 338 adults with obesity to escalating retatrutide doses or placebo over 48 weeks

The maker of Wegovy is threatening to sue and take regulatory action, saying Hims & Hers' new weight loss medication is illegal and calling it an "unapproved, inauthentic and untested knockoff semaglutide pill." "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety

It is hard to know how often these are truly caused by the peptides

It is important to seek medical attention right away if you experience any serious side effects while taking Wegovy